<- Go Home
Syncona Limited
Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.
Market Cap
GBP 667.8M
Volume
485.4K
Cash and Equivalents
GBP 1.9M
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
GBP 20.3M
Profit Margin
100.00%
52 Week High
GBP 1.10
52 Week Low
GBP 0.87
Dividend
N/A
Price / Book Value
0.64
Price / Earnings
-75.73
Price / Tangible Book Value
0.64
Enterprise Value
GBP 665.9M
Enterprise Value / EBITDA
N/A
Operating Income
-GBP 5.2M
Return on Equity
0.84%
Return on Assets
-0.30
Cash and Short Term Investments
GBP 1.9M
Debt
N/A
Equity
GBP 1.0B
Revenue
GBP 20.3M
Unlevered FCF
-GBP 15.9M
Sector
Capital Markets
Category
N/A